PLOD1 Gene

Last updated on: 25.09.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The PLOD1 gene (PLO stands for procollagen lysine,2-oxoglutarate 5-dioxygenase 1) is a protein-coding G located on chromosome 1p36.22. Two transcript variants encoding different isoforms have been found for this gene.

General informationThis section has been translated automatically.

The encoded gene product a "lysylhydroxylase" is a membrane-bound homodimeric enzyme localized in the cisternae of the endoplasmic reticulum. The enzyme protein PLOD1 (cofactors iron and ascorbate) complexes with P3H3 and P3H4. This complex catalyzes the hydroxylation of lysine residues into collagen alpha chains. This process is required for the normal assembly and cross-linking of collagen fibrils. These resulting hydroxylysines serve as binding sites for carbohydrate moieties and are essential for the stability of intermolecular collagen cross-links.

Diseases associated with PLOD1 include kyphoscoliotic Ehlers-Danlos syndrome (formerly:type VI). These patients are deficient in lysylhydroxylase activity. An important paralog of this gene is PLOD2.

Note(s)This section has been translated automatically.

The diagnosis of PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome is made in a subject with typical clinical findings and biallelic pathogenic (or likely pathogenic) PLOD1 variants identified by molecular genetic testing. If only one or no pathogenic variant is identified, testing for a markedly elevated urinary deoxypyridinoline to pyridinoline crosslink ratio measured by high-performance liquid chromatography (HPLC) may be required to confirm the diagnosis .

LiteratureThis section has been translated automatically.

  1. Brady A et al (2017): Ehlers-Danlos syndromes, rarer types. In: Ehlers-Danlos Society. American Journal of Medical Genetics 175C:70-115.
  2. Brinckmann J (2018) Hereditary connective tissue disorders. In. Plewig et al (eds) Braun-Falco`s Dermatology, Venereology and Allergology, Springer Reference Medicine pp 883-890.
  3. Bowen et al.(2017): Ehlers-Danlos syndrome, classical type. American Journal of Medical Genetics 175C:17-39.
  4. Yeowell HN et al. (2022) PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome. 2000 Feb 2 [updated 2018 Oct 18]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022.

Last updated on: 25.09.2022